Features Partner Sites Information LinkXpress
Sign In

Neurostimulation Systems Earn CE Marking for Use with Full-Body MRI Scans

By Medimaging International staff writers
Posted on 13 Feb 2013
Print article
Image: The SureScan line of neurostimulation systems for the treatment of chronic pain are designed for compatibility with full-body MRI scans (Photo courtesy of Medtronic).
Image: The SureScan line of neurostimulation systems for the treatment of chronic pain are designed for compatibility with full-body MRI scans (Photo courtesy of Medtronic).
The first implantable neurostimulation systems for use in the treatment of leg pain and/or chronic back are designed to be compatible with full-body magnetic resonance imaging (MRI) scans under specific conditions. The systems were recently introduced in Europe.

Medtronic, Inc.’s (Minneapolis, MN, USA) neurostimulation systems for the treatment of chronic pain recently received Conformité Européenne (CE) Marking approval for compatibility with full-body MRI scans. Neurostimulation systems enhanced with this technology and using Vectris SureScan MRI leads include: RestoreSensor SureScan MRI, PrimeAdvanced SureScan MRI, RestoreAdvanced SureScan MRI, and RestoreUltra SureScan MRI. Medtronic SureScan neurostimulation systems for the treatment of chronic pain are not approved by the US Food and Drug Administration for use in the United States.

“Neurostimulation therapy has become a mainstay of chronic pain management, and the introduction of full-body, MRI-compatible spinal cord stimulation systems is an important advancement that will help ensure neurostimulation patients have access to the diagnostic tools needed to quickly identify potentially critical health conditions,” said Dr. JP Van Buyten from the AZ Niklaas Hospital (Sint-Niklaas, Belgium).

As recent technologic development have increased MRI effectiveness and patient comfort, MRI use has increased dramatically in recent years. It is estimated that 60 million MRI scans are performed worldwide yearly. In Western Europe alone, 29 million scans were performed in 2010, with the number of scans doubling every five years.

Medtronic SureScan neurostimulation systems fulfill a vital medical need for full-body MRI compatibility by enabling patients who are receiving Medtronic neurostimulation therapy for chronic back and/or leg pain (also called spinal cord stimulation [SCS]) to have access to the advantages of full-body MRI. SCS patients, up to now, were denied full-body MRI scans because of worries that the system being affected by the large magnets involved in MRI.

“Delivering systems that are compatible with a full-body MRI scan means that spinal cord stimulation patients will not have to compromise when it comes to their healthcare, and they can feel secure knowing that MRI is a diagnostic option,” said Julie Foster, general manager and vice president, pain stimulation and targeted drug delivery in the neuromodulation business of Medtronic, Inc. “Medtronic’s development of these systems is another example of our commitment to advancing increasingly innovative and cost effective solutions that make it easier for clinicians to safely, effectively, and efficiently diagnose and treat the patients they serve.”

Medtronic SureScan neurostimulation systems include enhancements to existing devices as well as specially designed leads to reduce or eliminate the dangers generated by the MRI setting. The devices also include a proprietary SureScan programming feature, which sets the device into a suitable mode for the MRI environment.

Medtronic neurostimulation therapy for chronic pain uses a medical device positioned under a patient’s skin to deliver mild electrical impulses to the spinal cord, which act to block pain signals from going to the brain. Patients feel a tingling sensation from the neurostimulation Instead of pain in areas where they had earlier experienced pain.

Related Links:

Print article



view channel
Image: New Scenaria SE 64/128-slice Computed Tomography Scanner from Hitachi Medical Systems America (Photo courtesy of Business Wire).

Two new 64/128-Slice CT Scanners Cleared by the FDA

A major diagnostic imaging equipment provider has announced US FDA clearance of two new 64/128-slice Computed Tomography (CT) scanners. The Food and Drug Administration (FDA; Silver Spring, MD, USA)... Read more


view channel
Image: The connected Lumify with two advanced ultrasound transducers (Photo courtesy of Royal Philips).

Ultraportable Ultrasounds Plug into a Smartphone

Advanced hand-held ultrasound (US) transducers and an app-based online portal and subscription platform provide a comprehensive, connected digital imaging solution. The Philips Lumify is a complete... Read more

Nuclear medicine

view channel
Image: Glioblastoma in a PET scanner with (left) and without (right) the YY146 marker (Photo courtesy of Weibo Cai, WISC).

Antibody Cancer Marker Causes Tumors to Light Up

A novel marker attaches to a molecule on highly aggressive brain cancer, resulting in glioblastoma tumor tissue being easily identified in a positron emission tomography (PET) scanner. Developed by... Read more

Imaging IT

view channel

Rebuilt Web-Version of Free Mobile Healthcare Network Launched

A new, redesigned web version of a free mobile-first network, that enables radiologists and other healthcare professionals to view and share medical cases, has been launched and is slated to be showcased at the annual meeting of the Radiological Society of North America (RSNA 2015) during November 29–December 4, 2015).... Read more

Industry News

view channel

Long-Term Strategic Managed Medical Equipment Services Partnership Announced

An 18-year strategic collaboration agreement, worth CAD 300 million, between a major medical imaging vendor and the Southwest York Region of Ontario in Canada, has been announced. The partnership is for managed equipment services to help advance medical technology in the Southwest York region, and to expand the accessibility... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.